BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26173007)

  • 1. Sample Size Calculation: Inaccurate A Priori Assumptions for Nuisance Parameters Can Greatly Affect the Power of a Randomized Controlled Trial.
    Tavernier E; Giraudeau B
    PLoS One; 2015; 10(7):e0132578. PubMed ID: 26173007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of nuisance parameters in pediatric versus adult randomized trials: a meta-epidemiologic empirical evaluation.
    Vandermeer B; van der Tweel I; Jansen-van der Weide MC; Weinreich SS; Contopoulos-Ioannidis DG; Bassler D; Fernandes RM; Askie L; Saloojee H; Baiardi P; Ellenberg SS; van der Lee JH
    BMC Med Res Methodol; 2018 Jan; 18(1):7. PubMed ID: 29321002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size adaptation in fixed-dose combination drug trial.
    James Hung HM; Wang SJ
    J Biopharm Stat; 2012; 22(4):679-86. PubMed ID: 22651108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size calculations for randomized clinical trials published in anesthesiology journals: a comparison of 2010 versus 2016.
    Chow JTY; Turkstra TP; Yim E; Jones PM
    Can J Anaesth; 2018 Jun; 65(6):611-618. PubMed ID: 29569142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robustness of methods for blinded sample size re-estimation with overdispersed count data.
    Schneider S; Schmidli H; Friede T
    Stat Med; 2013 Sep; 32(21):3623-35. PubMed ID: 23595966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data.
    Harden M; Friede T
    Biom J; 2020 Sep; 62(5):1284-1299. PubMed ID: 32128868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size reassessment in non-inferiority trials. Internal pilot study designs with ANCOVA.
    Friede T; Kieser M
    Methods Inf Med; 2011; 50(3):237-43. PubMed ID: 20213039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size re-estimation in cluster randomization trials.
    Lake S; Kammann E; Klar N; Betensky R
    Stat Med; 2002 May; 21(10):1337-50. PubMed ID: 12185888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review.
    Nikolakopoulos S; Roes KC; van der Lee JH; van der Tweel I
    Trials; 2014 Jul; 15():274. PubMed ID: 25004909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study.
    Teare MD; Dimairo M; Shephard N; Hayman A; Whitehead A; Walters SJ
    Trials; 2014 Jul; 15():264. PubMed ID: 24993581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II error and statistical power in reports of small animal clinical trials.
    Giuffrida MA
    J Am Vet Med Assoc; 2014 May; 244(9):1075-80. PubMed ID: 24739118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size for testing difference between two proportions for the bilateral-sample design.
    Qiu SF; Tang NS; Tang ML; Pei YB
    J Biopharm Stat; 2009 Sep; 19(5):857-71. PubMed ID: 20183448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical power, sample size, and their reporting in randomized controlled trials.
    Moher D; Dulberg CS; Wells GA
    JAMA; 1994 Jul; 272(2):122-4. PubMed ID: 8015121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?
    Hernández AV; Eijkemans MJ; Steyerberg EW
    Ann Epidemiol; 2006 Jan; 16(1):41-8. PubMed ID: 16275011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving small-sample inference in group randomized trials with binary outcomes.
    Westgate PM; Braun TM
    Stat Med; 2011 Feb; 30(3):201-10. PubMed ID: 21213338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive clinical endpoint bioequivalence studies with sample size re-estimation based on a nuisance parameter.
    Zhu L; Sun W
    J Biopharm Stat; 2019; 29(5):776-799. PubMed ID: 31505986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.